Advanced search
Publication Cover
International Journal of Psychiatry in Clinical Practice Volume 6, 2002 - Issue 1
Submit an article Journal homepage
40
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Fluvoxamine for the treatment of depression and parkinsonism in progressive supranuclear palsy

Tsuyoshi Miyaoka
,
Haruo Seno
,
Takuji Inagaki
&
Jun Horiguchi
Pages 45-47 | Published online: 12 Jul 2009

  • Steele JC, Richardson JC, Olzewski J (1964) Progressive supranuclear palsy. Arch Neurol 10: 333-58.
  • Steele JC (1972) Progressive supranuclear palsy. Brain 95: 693-704.
  • Chin HF, Li SW (1996) Progressive supranuclear palsy presenting with psychiatric features. Br J Clin Pract 30: 60-61.
  • Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 47: 1-9.
  • Litvan I, Campbell G, Mangone CA et al (1997) Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 120: 65-74.
  • Perkin GD, Lees AJ, Stern GM et al (1978) Problems in the diagnosis of progressive supranuclear palsy. Can J Neurol Sci 2: 167-73.
  • Agid Y, Jayoy-Agid F, Ruberg M et al (1986) Progressive supranuclear palsy; anatomical and biochemical considerations. In: Yahr MD, Bergmam KJ (eds) Advances in Neurology, vol 45. Raven Press, New York, pp 191-201.
  • Tagliavini F, Pilleri G, Bouras C et al. (1984) The basal nucleus of Mynert in patients with progressive supranuclear palsy. Neurosci Lett 44: 37-41
  • Jellinger K, Riederer P, Tomonaga M (1980) Progressive supranuclear palsy; clinico-pathological and biochemical studies. J Neural Trans 16 (suppl): 111-128.
  • Engel PA (1996) Treatment of progressive supranudear palsy with amitriptyline: Therapeutic and toxic effects. J Am Geriatr Soc 44: 1072-74.
  • Kompoliti K, Goetz CG, Litvan I et al (1998) Pharmacological therapy in progressive supranuclear palsy. Arch Neurol 55: 1099-1101
  • Kvale JN (1982) Amitriptyline in the management of progressive supranuclear palsy. Arch Neurol 39: 387-88.
  • Nieforth KA, Golbe LI (1993) Retrospective study of drug response in 87 patients with progressive supranuclear palsy. Clin Neuropharmacol 16: 338-46.
  • Schneider LS, Gleason RP, Chui HC (1989) Progressive supranuclear palsy with agitation: response to trazodone but not to thiothixine or carbamazepine. J Geriatr Psychiatry Neurol 2: 109-12.
  • Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-61
  • Fahn S, Elton RL, and Members of the UPDRS Development Committee (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent Developments in Parkinson's Disease, vol 2. MacMillan Health Care Information, Florham Park, NJ, pp 153-164.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.